Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/26288

Title:	Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus
Authors:	Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Bilim Dalı. 0000-0002-0710-0923 Ersoy, Alparslan Ersoy, Canan Tekçe, Hikmet Yavaşçaoǧlu, İsmet Dilek, Kamil AAH-5054-2021 35612977100 6701485882 16687238400 6603612497 56005080200
Keywords:	Immunology Surgery Transplantation Kidney-transplantation Allograft recipients Patient survival Randomized-trial Risk-factors Mellitus Immunosuppression Cyclosporine Insulin FK506
Issue Date:	Jun-2004
Publisher:	Elsevier Science
Citation:	Ersoy, A. vd. (2004). “Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus”. Transplantation Proceedings, 36(5), 1407-1410.
Abstract:	Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplant recipient following de novo development associated with tacrolimus.
URI:	https://doi.org/10.1016/j.transproceed.2004.04.080 https://www.sciencedirect.com/science/article/pii/S0041134504005123 http://hdl.handle.net/11452/26288
ISSN:	0041-1345
Appears in Collections:	Scopus Web of Science

Files in This Item:

There are no files associated with this item.

DSpace JSPUI